First-in-human study of RAG-01, a novel small activating RNA therapeutic in BCG failure Non-Muscle Invasive Bladder Cancer (NMIBC) patients(Abstract)

Event： 40th Annual Congress of the European Association of Urology (EAU 2025) (Spain) View Abstract View Press Release: Ractigen’s RAG-01 Shows Promising Early Complete Responses in Phase I NMIBC Trial, Data Presented at EAU 2025

The release as fetched from its publisher. ractigen.com ↗